Clinical guidance on any issue changes as new medications, interventions, technologies, and best practices emerge and new studies come out. That is certainly true of PALTmed’s Clinical Practice Guidelines (CPGs). The just-revised Diabetes Management in the Post-Acute and Long-Term Care Setting CPG includes...
During the program, Naushira Pandya, MD, CMD, talked about her study, Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational Study. “One reason I wanted to do this study was the high prevalence of diabetes in long-term care,” where, she said, up to 44% of patients have t...
To characterize prescribing of glucose-lowering medication annually and to quantify the annual frequency of hypoglycemia among residents in long-term care (LTC) facilities with type 2 diabetes mellitus (T2DM).
Diabetes mellitus (DM) is associated with risk of sarcopenia. However, whether glycated hemoglobin (HbA1c) levels are associated with sarcopenia has not reached a consensus. The purpose of this study was to examine the association between diabetes status based on HbA1c levels and sarcopenia indices in comm...
Diabetes self-care may become increasingly challenging as cognition declines. We sought to characterize glycated hemoglobin A (HbA) trajectories, markers of diabetes-related management, health care utilization, and mortality in people with preexisting type 2 diabetes (T2D) with and without dementia and bas...
To examine the effect of aerobic and resistant exercise intervention on inflammaging in middle-aged and older adults with type 2 diabetes mellitus (T2DM) using inflammatory cytokines, such as interleukin (IL)-1 β, IL-6, tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) as biomarkers.